Healthcare AI startup Innovaccer has secured $275 million in Series F funding to advance its Healthcare Intelligence Cloud, enhance population health management, and introduce innovative tools like clinical decision support.

The series F round, which saw participation from industry giants like B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12, underscores Innovaccer’s growing influence.

“Innovaccer is dedicated to transforming healthcare through data-driven insights and cutting-edge AI technology. This funding will enable us to push the boundaries of what’s possible in healthcare AI. Our goal is to make healthcare more proactive, predictive, and personalized,” said Abhinav Shashank, Co-founder and CEO of Innovaccer.

Founded in 2014, Innovaccer empowers healthcare organizations with cutting-edge AI and cloud solutions. With its latest funding, the company plans to enhance collaboration with existing customers, expand its offerings with AI copilots and agents, and build a robust developer ecosystem. These tools will revolutionize utilization management, clinical decision support, care management, and contact center services, paving the way for smarter healthcare solutions.

Innovaccer’s Proven Excellence

Innovaccer’s platform, recognized with multiple Best-in-KLAS awards in data and analytics, population health management, and CRM, is a testament to its commitment to excellence. Currently serving six of the top ten US health systems, Innovaccer has also forged strong public-sector partnerships, including collaborations with San Mateo County and Alameda County.

The company supports over 130 healthcare organizations worldwide, achieving an impressive 50 percent year-over-year revenue growth for five consecutive years.

“Innovaccer has a vision for how data and AI can power the future of healthcare that aligns with the opportunities for AI we see at Danaher,” said Julie Sawyer Montgomery, Executive Vice President at Danaher Corporation.

To date, Innovaccer has raised $675 million, with its valuation now exceeding $3.4 billion. Over the past year, the company has strategically enhanced its capabilities through acquisitions, including Cured and Pharmacy Quality Solutions. These moves solidify Innovaccer’s position as a leader in healthcare AI, enabling the company to tackle the administrative challenges healthcare providers face while improving patient outcomes.

A Vision for the Future

Innovaccer’s CEO, Abhinav Shashank, emphasized the company’s mission to activate healthcare data flows, turning fragmented systems into cohesive solutions. The company’s AI-powered Healthcare Intelligence Cloud equips providers, payers, and government agencies with tools to elevate care quality while optimizing operational performance.

With its latest funding round, Innovaccer is well-positioned to redefine healthcare’s future. By integrating cutting-edge AI, fostering global collaborations, and driving value-based care, the company continues to lead the charge toward a more connected and efficient healthcare ecosystem.

“Innovaccer and other industry leaders to tackle some of healthcare’s biggest challenges. We believe that by providing clinicians with the data and analytics to drive meaningful clinical insights more quickly, at the point of need, we can accelerate the transition to more effective, more personalized care,” added Julie Sawyer Montgomery.

Stay ahead of the curve and follow IndiaTechDesk on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in India.